Mind Medicine (NASDAQ: MNMD) is a psychedelic medicine biotechnology company that started trading on the Nasdaq exchange on Tuesday.
MNMD stock is no stranger to the public exchange as shares of Mind Medicine have been listed on the OTC exchange under the ticker “MMEDFâ€. As part of the MNMD stock debut, shares of MindMed will graduate to the Nasdaq exchange but will retain its listing on the Canadian Neo Exchange under the ticker “MMEDâ€.
Are you looking for fast-news, hot-tips and market analysis?
Sign-up for the Invezz newsletter, today.
The much anticipated Mind Medicine stock debut was not met with investor enthusiasm as MNMD closed the session lower by nearly 30% at $4.02. Investors and traders will likely be keeping a close eye on Mind Medicine stock for signs of a rebound over the coming days and weeks.
With this in mind, this page will help you identify the best places to buy Mind Medicine stock.
Buying MNMD stock and buying shares of any company in 2021 is a straightforward task. If you want to buy Mind Medicine stock right now, your best option is through a reliable and trustworthy stock broker. While individual platforms vary in terms of how they look, they all perform the same basic task of buying and selling shares with low/no fees.
Our team of financial experts spent extensive periods of time evaluating different stock platforms to determine the best way of buying MindMed stock. We have concluded that the following 2 stock brokers are the best places to buy MindMed stock.
One of the more popular brokers in 2021 is eToro. The stock broker is among the most reputable brokers in the world and will see its own shares list on the Nasdaq exchange as part of a $10 billion SPAC deal. The platform is perhaps best known for integrating social trading and offers low deposit requirements.
If you want to buy Mind Medicine stock quickly and easily, eToro is a safe and convenient choice. Get started by clicking the link below.
Skilling is a Contract For Difference (CFD) and forex broker that is certainly no stranger to trading stocks. Skilling offers a modern mobile app and offers the convenience of a desktop platform as well.
Skilling was founded in 2016 and is licensed to offer its services in all EEA countries and many other countries worldwide. Buying MNMD stock on Skilling is a safe and convenient choice, especially for investors that prioritize simplicity. Sign up by clicking the link below.
Mind Medicine stock, or MindMed stock, engages in the discovery, development, and deployment of psychedelic inspired medicines and therapies. The company’s therapies are designed to address addiction and mental illness.
One of the company’s therapies, called 18-MC, attempts to treat the part of the brain that causes addiction, rather than just the symptoms.
MindMed stock might appeal to investors looking for exposure to innovative companies working on the future of psychedelic inspired medicines and therapies.
Mind Medicine is in the pre-revenue stage and ended 2020 with a net and comprehensive loss of $35.1 million. Management cautioned investors in a March 2021 disclosure it expects losses to fluctuate from quarter to quarter and year to year.
The case for buying Mind Medicine’s stock is based on management’s estimated total addressable market of 21 million Americans who suffer from at least one addiction. Mind Medicine also addresses unmet needs among the 10 million Americans who suffer from ADHD and the 284 million people who suffer from anxiety worldwide.
There is good reason to be afraid. Previous down markets have seen declines in excess…
United Parcel Service, Inc. (NYSE:UPS) and FedEx Corporation (NYSE:FDX) are two robust logistics companies. Both…
Canadian crypto mining firm Bitfarms sold roughly $62 million worth of Bitcoin (BTC) in June,…
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling…
Noma, a Japanese film studio, has announced that it is producing three feature films that…
Bitcoin (BTC) saw continued strength on June 21 as Wall Street trading opened with a…